Raju S. Kucherlapati

Raju S. Kucherlapati is a declared insider at 4 companies; the most frequent names are Millennium Pharmaceuticals Inc, Aveo Pharmaceuticals, Inc. and Abgenix Inc. The record holds 49 filings, for trades running from 13 March 2006 to 21 November 2022.

Market trades split into 9 purchases (€616k) and 13 sales (€584k). Purchases outweigh sales by €32k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 9 option exercises. So far in 2022, the count stands at 4 purchases and no sales.

A typical purchase (the median) is worth €53k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 22 November 2022, reports an open-market purchase of €40k in Gelesis Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.